106 information-security-"https:"-"https:"-"https:"-"https:"-"https:"-"U.S" positions at BIOMEDICAL SCIENCES RESEARCH CENTRE "ALEXANDER FLEMING"
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Overview Eine Druckversion dieser Ausschreibung (PDF) steht Ihnen in den weiteren Registerkarten (z.B. „Bewerbungsvoraussetzungen“) zur Verfügung. A print version of this announcement (PDF) is
-
About the role: This is an exciting opportunity to join one of the newly announced Gram-negative Antimicrobial Innovator (Gr-ADI) programs, launched by the Wellcome Trust, the Gates Foundation, and
-
their application from classical homogeneous systems into heterogeneous covalent organic framework (COF)-based organocatalysts. The goal is to disentangle intrinsic catalytic turnover from mass-transport and surface
-
This role is part of the Julia Anderson Training Programme which provides individuals who are at the early stage of their career with hands-on experience working on projects or activities conducted
-
on healthcare, research, and teaching, we bear a unique responsibility - ideally with you on board! The position is located in the research group of Dr. med. Alexander Busch, PhD and embedded in the DGF-funded
-
events with the GOTO telescope network. Projects focussing on thermonuclear bursts will involve analysis of new and archival data from satellite-based X-ray telescopes, and running numerical models
-
. The mechanisms by which cells transition from pluripotent to differentiated states is incompletely understood, and correlating measurable parameters to identify efficient culture conditions and release criteria
-
Overview Eine Druckversion dieser Ausschreibung (PDF) steht Ihnen in den weiteren Registerkarten (z.B. „Bewerbungsvoraussetzungen“) zur Verfügung. A print version of this announcement (PDF) is
-
Max Planck Institute of Immunobiology and Epigenetics, Freiburg | Freiburg im Breisgau, Baden W rttemberg | Germany | about 2 months ago
, MSCA, Alexander von Humboldt, DFG Walter Benjamin). The starting date is flexible, between July and December 2026. The Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) in Freiburg, Germany
-
deficiencies in humans’, focusing on investigating the absorption and bioavailability of novel mineral sources in vivo in clinical trials. Micronutrient deficiency is a widespread global health problem